Using published datasets, we show that in these comorbid diseases, SPINT2 is downregulated, which might lead to an increase of the infectivity of cells in disease-tissues such as endocrine cells of diabetic patients or cells from tumor tissues. Here, SPINT2 is linked to neoplasm.